Melanocortin subtype-2 receptor (mc2r) antagonist for the treatment of disease
Номер патента: EP4308553A1
Опубликовано: 24-01-2024
Автор(ы): Alan S. KRASNER, Christine FERRARA-COOK
Принадлежит: Crinetics Pharmaceuticals Inc
Опубликовано: 24-01-2024
Автор(ы): Alan S. KRASNER, Christine FERRARA-COOK
Принадлежит: Crinetics Pharmaceuticals Inc
Реферат: Provided herein are methods and compositions for the treatment of diseases of ACTH excess, such as Cushing's disease, ectopic ACTH syndrome, and congenital adrenal hyperplasia.
Melanocortin subtype-2 receptor (mc2r) antagonist for the treatment of disease
Номер патента: US20220313691A1. Автор: Christine FERRARA-COOK,Alan S. KRASNER. Владелец: Crinetics Pharmaceuticals Inc. Дата публикации: 2022-10-06.